Smaller sized doses for perioral treatment than for higher facial apps are used since the oral musculature responds more strongly to the same BTX-A dosing. Just one preparation of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA acceptance lies in treatments of cervical dystonia. The oral https://botulinumtoxins64714.tribunablog.com/botulinum-toxin-symptoms-fundamentals-explained-49998111